About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us
More Company News
Avacta
AffyXell JV milestone and increased equity stake
13 Apr 2022
Read More
Avacta
AVA6000 poster presented at AACR
12 Apr 2022
Read More
Avacta
AffyXell JV partners with Biocytogen and KNTSC
08 Apr 2022
Read More
Avacta
Preliminary FY21 results
06 Apr 2022
Read More
Avacta
AVA6000 preclinical data to be presented at AACR
29 Mar 2022
Read More
Avacta
Vimian acquires Avacta’s Animal Health Division
16 Mar 2022
Read More
Avacta
Dose escalation in AVA6000 Phase I study
03 Feb 2022
Read More
Avacta
Second pre|CISION pro-drug candidate selected
18 Jan 2022
Read More
Avacta
Update on AffiDX and detection of Omicron variant
10 Jan 2022
Read More
Avacta
AffiDX LFT receives CE Mark for consumer self-testing
22 Dec 2021
Read More
1
2
3
Return to Avacta
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
▼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us